These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3014883)

  • 1. Prognostic value of peritoneal washings in patients with malignant mixed müllerian tumors of the uterus.
    Geszler G; Szpak CA; Harris RE; Creasman WT; Barter JF; Johnston WW
    Am J Obstet Gynecol; 1986 Jul; 155(1):83-9. PubMed ID: 3014883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritoneal cytology in malignant mixed müllerian tumors of the uterus.
    Kanbour AI; Buchsbaum HJ; Hall A; Kanbour AI
    Gynecol Oncol; 1989 Apr; 33(1):91-5. PubMed ID: 2539314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in malignant mesodermal (mullerian) mixed tumors of the uterus.
    Macasaet MA; Waxman M; Fruchter RG; Boyce J; Hong P; Nicastri AD; Remy JC
    Gynecol Oncol; 1985 Jan; 20(1):32-42. PubMed ID: 2981189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of cytologic examination of peritoneal washings in patients with endometrial carcinoma.
    Szpak CA; Creasman WT; Vollmer RT; Johnston WW
    Acta Cytol; 1981; 25(6):640-6. PubMed ID: 6171978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant mixed müllerian tumors of the uterus. A clinicopathologic assessment of 34 cases.
    Barwick KW; LiVolsi VA
    Am J Surg Pathol; 1979 Apr; 3(2):125-35. PubMed ID: 231382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed müllerian tumors of the uterus: a clinicopathologic study.
    Dinh TV; Slavin RE; Bhagavan BS; Hannigan EV; Tiamson EM; Yandell RB
    Obstet Gynecol; 1989 Sep; 74(3 Pt 1):388-92. PubMed ID: 2548134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of peritoneal cytology in endometrial carcinoma.
    Harouny VR; Sutton GP; Clark SA; Geisler HE; Stehman FB; Ehrlich CE
    Obstet Gynecol; 1988 Sep; 72(3 Pt 1):394-8. PubMed ID: 3405555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical-pathologic study of mixed müllerian tumors of the uterus over a 16-year period--the Medical College of Georgia experience.
    Gallup DG; Gable DS; Talledo OE; Otken LB
    Am J Obstet Gynecol; 1989 Sep; 161(3):533-8; discussion 538-9. PubMed ID: 2551168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic analysis of uterine malignant mixed müllerian tumors.
    Nielsen SN; Podratz KC; Scheithauer BW; O'Brien PC
    Gynecol Oncol; 1989 Sep; 34(3):372-8. PubMed ID: 2548936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant mixed Mullerian tumours of the uterus--a ten-year experience.
    Ho SP; Ho TH
    Singapore Med J; 2002 Sep; 43(9):452-6. PubMed ID: 12568422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of malignant, mixed mesodermal tumors of the uterus.
    Podczaski ES; Woomert CA; Stevens CW; Manetta A; Larson JE; Zaino RJ; Mortel R
    Gynecol Oncol; 1989 Feb; 32(2):240-4. PubMed ID: 2536000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic features of sarcomas and mixed tumors of the endometrium.
    Peters WA; Kumar NB; Fleming WP; Morley GW
    Obstet Gynecol; 1984 Apr; 63(4):550-6. PubMed ID: 6322081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosarcoma of the uterus: a Gynecologic Oncology Group clinicopathologic study of 31 cases.
    Kaku T; Silverberg SG; Major FJ; Miller A; Fetter B; Brady MF
    Int J Gynecol Pathol; 1992; 11(2):75-88. PubMed ID: 1316323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Malignant mesodermal mixed tumor of the uterus--a study of 37 cases].
    Zhang WH
    Zhonghua Zhong Liu Za Zhi; 1991 Sep; 13(5):378-80. PubMed ID: 1664319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterologous mixed müllerian tumor confined to an endometrial polyp.
    Barwick KW; LiVolsi VA
    Obstet Gynecol; 1979 Apr; 53(4):512-4. PubMed ID: 220575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticals.
    Creasman WT; Disaia PJ; Blessing J; Wilkinson RH; Johnston W; Weed JC
    Am J Obstet Gynecol; 1981 Dec; 141(8):921-9. PubMed ID: 7315922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of clinicopathologic factors in malignant mixed Müllerian tumors of the uterine corpus.
    Inthasorn P; Carter J; Valmadre S; Beale P; Russell P; Dalrymple C
    Int J Gynecol Cancer; 2002; 12(4):348-53. PubMed ID: 12144682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of cytologic peritoneal washings.
    Willett GD
    Clin Lab Med; 1985 Jun; 5(2):265-74. PubMed ID: 3896625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal fluid cytology and prognosis in patients with endometrial carcinoma.
    Hirai Y; Fujimoto I; Yamauchi K; Hasumi K; Masubuchi K; Sano Y
    Obstet Gynecol; 1989 Mar; 73(3 Pt 1):335-8. PubMed ID: 2915858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant mixed Müllerian tumors of the uterus.
    Spanos WJ; Wharton JT; Gomez L; Fletcher GH; Oswald MJ
    Cancer; 1984 Jan; 53(2):311-6. PubMed ID: 6197155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.